Beneficial effects of thiazolidinediones on myocardial infarction risk in patients with type 2 diabetes

被引：0
|
作者：
Koro, CE
Fu, QG
Dirani, RG
Fedder, DO
机构：
来源：
DIABETES | 2004年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A247 / A247
页数：1
相关论文
共 50 条
  • [21] Cancer Risk for Patients Using Thiazolidinediones for Type 2 Diabetes: A Meta-Analysis
    Bosetti, Cristina
    Rosato, Valentina
    Buniato, Danilo
    Zambon, Antonella
    La Vecchia, Carlo
    Corrao, Giovanni
    ONCOLOGIST, 2013, 18 (02): : 148 - 156
  • [22] Beneficial effects of rosiglitazone on novel cardiovascular risk factors in patients with Type 2 diabetes mellitus
    Kadoglou, N. P. E.
    Iliadis, F.
    Angelopoulou, N.
    Perrea, D.
    Liapis, C. D.
    Alevizos, M.
    DIABETIC MEDICINE, 2008, 25 (03) : 333 - 340
  • [23] Myocardial Infarction Risk in Diabetes Patients with Depression
    Nowotny, B.
    DIABETOLOGE, 2011, 7 (06): : 415 - 415
  • [24] Improving Risk Stratification for Patients With Type 2 Myocardial Infarction
    Taggart, Caelan
    Monterrubio-Gomez, Karla
    Roos, Andreas
    Boeddinghaus, Jasper
    Kimenai, Dorien M.
    Kadesjo, Erik
    Bularga, Anda
    Wereski, Ryan
    Ferry, Amy
    Lowry, Matthew
    Anand, Atul
    Lee, Kuan Ken
    Doudesis, Dimitrios
    Manolopoulou, Ioanna
    Nestelberger, Thomas
    Koechlin, Luca
    Lopez-Ayala, Pedro
    Mueller, Christian
    Mills, Nicholas L.
    Vallejos, Catalina A.
    Chapman, Andrew R.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (02) : 156 - 168
  • [25] Myocardial infarction and type II diabetes - preferential treatment for high risk patients?
    Green, B
    Duffull, S
    Cottrell, N
    D'Emden, M
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2002, 27 (05) : 371 - 376
  • [26] Effect of gender on prognosis in patients with myocardial infarction and type 2 diabetes
    Venskutonyte, L.
    Malmberg, K.
    Norhammar, A.
    Wedel, H.
    Ryden, L.
    JOURNAL OF INTERNAL MEDICINE, 2010, 268 (01) : 75 - 82
  • [27] The effectiveness of β-blockers after myocardial infarction in patients with type 2 diabetes
    McDonald, CG
    Majumdar, SR
    Mahon, JL
    Johnson, JA
    DIABETES CARE, 2005, 28 (09) : 2113 - 2117
  • [28] Beneficial effects of C-peptide on myocardial function in patients with type 1 diabetes
    Hansen, A
    Johansson, BL
    Wahren, J
    von Bibra, H
    DIABETOLOGIA, 2001, 44 : A68 - A68
  • [29] A comparison of the effects of thiazolidinediones and metformin on metabolic control in patients with type 2 diabetes mellitus
    Seufert, J
    Lübben, G
    Dietrich, K
    Bates, PC
    CLINICAL THERAPEUTICS, 2004, 26 (06) : 805 - 818
  • [30] Risk of acute myocardial infarction in 121289 patients with type 2 diabetes: emphasis on socioeconomic status and ethnicity
    Svensson, A. -M.
    Rawshani, A.
    Rosengren, A.
    Gudbjornsdottir, S.
    DIABETOLOGIA, 2014, 57 : S138 - S138
12345